Table 3.

Immunohistochemical results for other markers

	MIC	PAC	FC	PDCa	UCa	AG	FA
Gal-3
(++)	100%	73%	0%	0%	0%	0%	0%
(+)	0%	27%	0%	0%	100%	0%	0%
(F+)	0%	0%	11%	50%	0%	0%	28%
(−)	0%	0%	73%	50%	0%	100%	72%
CK19
(++)	75%	88%	0%	0%	0%	0%	0%
(+)	25%	61%	0%	0%	100%	0%	0%
(F+)	0%	0%	33%	50%	0%	20%	28%
(−)	0%	0%	67%	50%	0%	80%	72%
HBME-1
(++)	75%	85%	0%	0%	0%	0%	0%
(+)	17%	10%	0%	0%	0%	0%	0%
(F+)	8%	0%	11%	50%	0%	10%	11%
(−)	0%	5%	89%	50%	100%	90%	56%
Cyclin D1
(++)	100%	95%	0%	0%	0%	0%	0%
(+)	0%	0%	0%	50%	0%	0%	0%
(F+)	0%	0%	11%	50%	100%	0%	17%
(−)	0%	5%	89%	0%	0%	100%	83%
Ki-67 L.I. (mean percentage
	5.2%	7.1%	3.3%	10%	65%	< 1%	2.9%

*Gal-3 Galectin-3, HBME-1 Hector Battifora mesothelial-1, CK cytokeratin

*MIC Microcarcinoma, PAC Papillary thyroidal carcinoma, FC Follicular carcinoma, PDCa Poorly differentiated carcinoma, UCa Undifferentiated carcinoma, AG Adenomatous goiter, FA Follicular adenoma

*(−), negative [0%]; (F+), focally positive [1–9%]; (+), positive [10–49%]; (++), diffusely positive [≥50%]; L.I., labeling index